NEW YORK (GenomeWeb News) – The International Serious Adverse Events Consortium (SAEC) plans to collaborate with the HMO Research Network (HMORN), a consortium of 16 health plans with 14 million members, to determine the feasibility of using HMORN's clinical data warehouse to study drug-induced serious adverse events.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.